Ophthalmology Doctors in Waterville, ME Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

James R Putnam, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 325a Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-2731    Fax: 207-873-1106

Peter C Kohler, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325a Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-2731    Fax: 207-873-1106

Dr. Clement W Lavin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 32 College Ave, Suite 304, Waterville, ME 04901 Phone: 207-872-9564    Fax: 207-861-5458

Deborah I Witkin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325a Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-2731    Fax: 207-873-1106

Marc B Daniels, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 40 Airport Rd, Ste 1, Waterville, ME 04901 Phone: 207-873-6048    Fax: 207-877-9513

Miss Nour Maya Haddad, M.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325a Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-2731    Fax: 207-873-1106

Dr. Steve Richard Witkin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325a Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-2731    Fax: 207-873-1106

Zachary George Klett, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 325a Kennedy Memorial Dr, Waterville, ME 04901 Phone: 207-873-2731    Fax: 207-873-1106

News Archive

Study finds link between high blood lead levels and pre-eclampsia

More than a century since a Brisbane doctor found that lead in paint destroyed children's lives, new research from Griffith University concludes that it is a major risk factor for pre-eclampsia.

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

Toronto nurses join In Labour Day parade

Front-line registered nurses from the Toronto area will join hundreds of union members marching in the city's Labour Day parade this long weekend.

NUHW files for union election, but refuses to sign agreement

Two weeks after filing for a union election among 46,000 Kaiser workers in California, the National Union of Healthcare Workers (NUHW) refused to sign an agreement that would allow the election to go forward in the next 60 days.

Alnylam receives U.S. patent allowance for LNP platform

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application number 12/813,448, covering the company's proprietary second generation lipid nanoparticle (LNP) platform, including the "MC3" lipid.

Read more Medical News

› Verified 5 days ago